Rapid quantitative determination of L-FMAU-TP from human peripheral-blood mononuclear cells of hepatitis B virus-infected patients treated with L-FMAU by ion-pairing, reverse-phase, liquid chromatography/electrospray tandem mass spectrometry
- Authors
- Lee, Jaeick; Yoo, Byung-Chul; Lee, Hyo-Suk; Yoo, Hee-Won; Yoo, Hye-Hyun; Kang, Min Jung; Kim, Dong-Hyun
- Issue Date
- Feb-2006
- Publisher
- Lippincott Williams & Wilkins Ltd.
- Keywords
- L-FMAU-TP; PBMCs; ion-pairing liquid chromatography; tandem mass spectrometry
- Citation
- Therapeutic Drug Monitoring, v.28, no.1, pp.131 - 137
- Indexed
- SCOPUS
- Journal Title
- Therapeutic Drug Monitoring
- Volume
- 28
- Number
- 1
- Start Page
- 131
- End Page
- 137
- URI
- https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/45044
- DOI
- 10.1097/01.ftd.0000194027.12107.11
- ISSN
- 0163-4356
- Abstract
- The purpose of this study was to develop an analytical method for the determination of 2'-fluoro-5-metliyl-beta-1-arabinofuranosyl uracil triphosphate (L-FMAU-TP) in human peripheral blood rnononuclear cells (PBMCs), and its application in the determination of cellular levels of L-FMAU-TP in PBMCs isolated front patients treated with 2'-fluoro-5-methyl-beta-1-arabinofurinosyl uracil (L-FMAU). An ion-pairing liquid chromatography (IPC) method, coupled with negative ion electrospray ionization tandem mass spectrometry (ESI-MS/MS), was developed for the accurate and repeatable detection of L-FMAU-TP. with a limit of detection of 1.6 pmol/10(6) cells. The calibration curve for L-FMAU-TP was linear over the concentration range 1.6 to 80 pmol/10(6) cells. The intra- and inter-day precision was lower than 11.2%, and the accuracy was between 97.1 and 106.9%. When applied to the determination of L-FMAU-TP in PBMCs isolated from HBV-infected patients undergoing L-FMAU treatment, the levels reached a steady state concentration 4 weeks after daily sin(2le oral administration of 20 Ing L-FMAU, and these levels were maintained for up to 12 weeks, but then decreased 12 weeks after drua cessation. The tenninal half-life of L-FMAU-TP in PBMCs after druLy cessation was estimated to be 15.6 days.
- Files in This Item
-
Go to Link
- Appears in
Collections - COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.